Skip to content
Screener

Integra LifeSciences IART Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
$2.05M+66.3%
Globus Medical logo
Globus MedicalGMED
$111.19M-8.2%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$9.16M+157%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
$1.53M+44.9%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$21.16M+19.7%
AngioDynamics logo
AngioDynamicsANGO
$5.16M+30.7%

Other financials

Income statement

See full
Revenue$418.8M+0.8%
Gross profit$219.7M+5.0%
Operating income$19.3M+104%
Net income$4.5M+101%
EPS (diluted)$0.06+101%

Balance sheet

See full
Cash & equivalents$214.4M-1.6%
Total debt$2.0B+3.2%
Total equity$1.0B+0.5%
Total assets$3.6B-2.8%

Cash flow

See full
Operating cash flow$22.8M+156%
CapEx$12.3M-38.9%
Free cash flow$10.5M+193%

Valuation

See full
Market cap$1.34B+35.1%
Enterprise value$3.09B+15.4%
P/S0.8×+0.2×

Profitability

See full
Gross margin52.5%-0.1pp
Operating margin2.6%+1.3pp
Net margin-0.4%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-0.7%
Debt / equity1.9×+0.1×
Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000917520-26-000058
Dollars in thousands, except lease term and discount rateJune 30, 2026December 31, 2025
ROU assets$137,085$140,568
Current lease liabilities13,92014,019
Non-current lease liabilities162,660163,059
Total lease liabilities$176,580$177,078
Weighted average remaining lease term (in years):
Leased facilities15.4 years15.7 years
Leased vehicles2.7 years2.7 years
Leased equipment2.9 years2.9 years

Item 1. Financial Statements

FAQ

What is Integra LifeSciences's operating lease liabilities (total)?
Integra LifeSciences (IART) reported operating lease liabilities (total) of $176.58M in Q2 2026.
How has Integra LifeSciences's operating lease liabilities (total) changed year-over-year?
Integra LifeSciences's operating lease liabilities (total) increased by 1.8% year-over-year, from $173.45M to $176.58M.
What is the long-term trend for Integra LifeSciences's operating lease liabilities (total)?
Over 5 years (2020 to 2025), Integra LifeSciences's operating lease liabilities (total) has grown at a 11.9% compound annual growth rate (CAGR), from $100.94M to $177.08M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about Integra LifeSciences's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude